ebook Munafa Stock Market Course + Intraday & FNO calls  

Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)

Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 19 Nov 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics

Protagonist Therapeutics Opened at 127.38 and Closed at: 124.02, which is -2.53% of previous session's close. It moved within a range of 123.67 and 128.89
The session was a Bearish session with an average volume of 554100, which is 21.89% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 6 days back on short term averages

Support for tomorrow is 121.24 and resistance for tomorrow is 126.46
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 122.16, 120.31 resistance for tomorrow's hourly charts is 127.38, 130.75

10 Day SMA for Protagonist Therapeutics (PTGX) is 130.51 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Protagonist Therapeutics (PTGX) is 135.73 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Protagonist Therapeutics (PTGX) is 138.68 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 140.65 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Protagonist Therapeutics is 120.42 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Protagonist Therapeutics is at 135.73 and 200 DMA is at 120.42, while 50 DMA and 100 DMA are at 138.68 and 140.65 respectively

Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 135.73 and 20 EMA is at 133.35

Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 138.68 and 50 EMA is at 136.89

Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 140.65 and 100 EMA is at 134.15

Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 120.42 and 200 EMA is at 121.45

Protagonist Therapeutics has performed better than Veracyte Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!

Bio Techne has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Bio Techne, about 10.62% more returns!

Protagonist Therapeutics has performed better than Redhill Biopharma in short term. Holding Protagonist Therapeutics could be a better choice for now!

Opko Health has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Opko Health, about 9.18% more returns!

Addus Homecare has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Addus Homecare, about 9.8% more returns!

Accuray Incorporated has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Accuray Incorporated, about 1541.18% more returns!

Protagonist Therapeutics has performed better than Geron Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!

Protagonist Therapeutics has performed better than Halozyme Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!

Henry Schein has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 10.22% more returns!

Protagonist Therapeutics has performed better than Inogen Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!

Neurocrine Biosciences has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 20.14% more returns!

Protagonist Therapeutics Technical analysis of indicators

Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Protagonist Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Protagonist Therapeutics in short term and the sell signal is strong.

Protagonist Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Protagonist Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 130.51 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.

Protagonist Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And PTGX Experts View which covers a lot of information including buying and selling signals

PTGX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here

Chart Protagonist Therapeutics (PTGX)  Technical (Analysis) Reports Protagonist Therapeutics [

Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Protagonist Therapeutics (PTGX)  Technical (Analysis) Reports Protagonist Therapeutics [

 

Back to top